NCT03307980: Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B
- State
- Stopped early
- Phase
- Phase 2
- People
- 21 taking part
- Started
- 22 Jun 2017
- Primary completion
- 23 Jul 2026
- Arms
- PF-06838435 Dose-Escalation
- Results
- None posted
- Papers
- doi:10.1007/s40262-025-01535-y, doi:10.1056/nejmoa2307159, doi:10.1182/bloodadvances.2025019174
- 22 Jun 2017: Trial started
- 12 Oct 2017: Trial registered
- 23 Jul 2026: Trial terminated